Vivos Therapeutics (VVOS) Earnings Date, Estimates & Call Transcripts $2.72 -0.12 (-4.05%) As of 02:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vivos Therapeutics Earnings Summary Upcoming Earnings DateMay. 13Before Market OpensEstimatedConsensus EPS (Mar. 27) -$0.43 Actual EPS (Mar. 27) -$0.28 Beat By $0.15 Actual Revenue (Mar. 27) $3.70MVivos Therapeutics released Q4 2024 earnings on March 27, 2025, reporting an EPS of -$0.28, which topped the consensus estimate of -$0.43 by $0.15. Quarterly revenue was reported to be $3.70 million, below analysts' expectations of $3.89 million. With a trailing EPS of -$2.91, Vivos Therapeutics' earnings are expected to grow next year, from ($1.79) to ($1.43) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Press Release (8-K)VVOS Upcoming EarningsVivos Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Vivos Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vivos Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVVOS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VVOS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Vivos Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.79) EPSNext Year EPS Consensus Estimate ($1.43) EPS Vivos Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)-------3/27/2025Q4 2024-$0.43-$0.28+$0.15-$0.28$3.89M$3.70M8/14/2024Q2 2024--$0.60 -$0.60-$0.60-$4.05M5/14/2024Q1 2024--$1.63 -$1.63-$1.63-$3.42M3/28/2024Q4 2023--$3.05 -$3.05-$3.05-$3.25M11/14/2023Q3 2023--$1.75 -$1.75-$1.75-$3.30M8/16/2023Q2 2023-$3.75-$3.75--$0.12$3.93M$3.40M6/8/2023Q1 2023-$4.25-$5.00 -$0.75-$0.33$3.71M$3.86M Vivos Therapeutics Earnings - Frequently Asked Questions When is Vivos Therapeutics's earnings date? Vivos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on VVOS's earnings history. Did Vivos Therapeutics beat their earnings estimates last quarter? In the previous quarter, Vivos Therapeutics (NASDAQ:VVOS) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.43) by $0.15. Learn more on analysts' earnings estimate vs. VVOS's actual earnings. How can I listen to Vivos Therapeutics's earnings conference call? The conference call for Vivos Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Vivos Therapeutics's conference call transcript? The conference call transcript for Vivos Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Vivos Therapeutics generate each year? Vivos Therapeutics (NASDAQ:VVOS) has a recorded annual revenue of $15.03 million. How much profit does Vivos Therapeutics generate each year? Vivos Therapeutics (NASDAQ:VVOS) has a recorded net income of -$13.58 million. VVOS has generated -$2.91 earnings per share over the last four quarters. What is Vivos Therapeutics's EPS forecast for next year? Vivos Therapeutics's earnings are expected to grow from ($1.79) per share to ($1.43) per share in the next year. More Earnings Resources from MarketBeat Related Companies ECOR Earnings Date APT Earnings Date SPAI Earnings Date TMDIF Earnings Date APYX Earnings Date OM Earnings Date TELA Earnings Date MODD Earnings Date FEMY Earnings Date POCI Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Microsoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of EarningsAmazon's Earnings Will Make or Break the Stock's Comeback CrowdStrike Stock Nears Record High, Dip Ahead of Earnings?Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock Up This page (NASDAQ:VVOS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VVOS Stock Free VVOS Stock Alerts